CVS vs IDXX: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

IDXX has stronger fundamentals based on our AI analysis.

CVS
CVS HEALTH Corp
HOLD
70%
Confidence
VS
IDXX
IDEXX LABORATORIES INC /DE
STRONG BUY
87%
Confidence

CVS vs IDXX Fundamental Comparison

Metric CVS IDXX
Revenue $402.1B $4.3B
Net Income $1.8B $1.1B
Net Margin 0.4% 24.6%
ROE 2.4% 66.0%
ROA 0.7% 31.6%
Current Ratio 0.84x 1.23x
Debt/Equity 0.85x 0.28x
EPS $1.39 $13.08

Green = Better metric | Red = Weaker metric

View Full CVS Analysis →
View Full IDXX Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

CVS vs AAPL IDXX vs MSFT CVS vs GOOGL IDXX vs AMZN

CVS vs IDXX: Frequently Asked Questions

Is CVS or IDXX a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), IDXX has stronger fundamentals. CVS is rated HOLD (70% confidence) while IDXX is rated STRONG BUY (87% confidence). This is not investment advice.

How does CVS compare to IDXX fundamentally?

CVS HEALTH Corp has ROE of 2.4% vs IDEXX LABORATORIES INC /DE's 66.0%. Net margins are 0.4% vs 24.6% respectively.

Which stock pays higher dividends, CVS or IDXX?

CVS has a dividend yield of N/A or no dividend while IDXX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in CVS or IDXX for long term?

For long-term investing, consider that CVS has HOLD rating with 70% confidence, while IDXX has STRONG BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about CVS vs IDXX?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs IDXX, the AI consensus favors IDXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.